The American Heart Association (AHA) and the Heart Failure Society of America (HFSA) have issued a new scientific statement on the management of comorbid type 2 diabetes mellitus (DM) and heart failure (HF).
The statement summarizes what is known about the epidemiology and pathology of DM and its impact on HF outcomes, reviews management of those with both conditions, and looks at opportunities for future research.
The statement was published online June 6 in Circulation, and in the Journal of Cardiac Failure.
